It has previously been reported from this laboratory (Saz and Slie, 1954a ) that chlortetracycline ("aureomycin") in concentrations of 1 to 100 ,ug per ml inhibited an enzyme complex from Escherichia coli strain E-26 mediating the reduction of chloramphenicol and other aromatic nitro compounds to the corresponding arylamines.
The cofactor requirements for this organic nitro reductase were found to be diphosphopyridine nucleotide (DPN) and i-malic acid (replaceable by reduced DPN), -cysteine and a divalent cation (Saz and Slie, 1954b) . In addition, by analogy with non-bacterial systems (Bueding and Jolliffe, 1946; Nason and Evans, 1953; Nicholas and Nason, 1955) In the present paper, the nitro reductase of aureomycm-resistant variants of sensitive E. coli proved resistant to aureomycin both in intact cells and cell-free extracts.
METHODS
Aureomycin-resistant E. coli was obtained by serial passage of the parent, sensitive strain in increasing concentrations of the antibiotic. A strain was finally derived which grew readily in the presence of aureomycin concentrations of 50 to 60 ,ug per ml. The sensitive strain was inhibited at antibiotic levels of 1.6 to 3.2 ,ug per ml. All cells were grown, harvested and extracted, and arylamine was determined as previously described (Saz and Slie, 1954a Effect of concentration of enzyme. Table 2 indicates that the degree of resistance of the extracts of resistant cells is apparently related to the amount of extract present in the assay. The greater the amount of resistant extract, the more aureomycin was required for inhibition. By contrast, with extracts of sensitive cells, the inhibitory concentration of aureomycin was completely unaffected by the concentration of enzyme.
Resistance and stdfhydryl source. It had previously been found (Saz and Slie, 1954a) that L-cysteine was essential for arylamine formation mediated by the sensitive extracts. D-Cysteine was Y4 to M as active as its enantiomorph. Other sulfhydryl-containing compounds such as 2,3-dimercaptopropanol (BAL), glutathione, coenzyme A and lipoic acid were inactive. Sulfhydryl compounds were similarly essential for nitro reductase activity of resistant extracts. Table 3 compares the effect of various sulfhydryl sources on arylamine formation by sensitive and resistant enzymes. It is evident that H2S can replace optimal concentrations of both L-and D-cysteine in both extracts, and indeed in certain concentrations is more effective than either in promoting reduction. Contrary to the results obtained with the sensitive extract, D-cysteine is somewhat more effective than the L-isomer in promoting arylamine formation by resistant extracts. This may Each tube contained 0.3 ml enzyme preparation, 5 X 10-' M tris (hydroxymethyl) aminomethane buffer, pH 7.5, 3 X 10-4 M chloramphenicol, 5 X 10-1 M L-cysteine. In addition, tubes with dialyzed extract contained 2 X 10-5 M DPN and 1 X 10-8 M L-malate. Total volume 1.5 ml. Incubated 37 C for 1 hour, aerobically. (Saz and Brownell, 1954 ) that both sensitive and resistant extracts possess potent D-cysteine desulfhydrase activity, the latter being 3 to 4 times more active than the former.
The two types of extract differ in still another respect with regard to the effect of sulfhydryl compounds. With extracts of sensitive cells, the inhibitory action of aureomycin on arylamine formation was the same whether the sulfhydryl source was D-cysteine, L-cysteine, mixtures of both, or H2S. With extracts of resistant cells, Since both sensitive and resistant extracts were diluted to contain equal concentrations of protein, table 3 also shows that the specific activity of resistant extracts is uniformly considerably greater than the activity of sensitive extracts.
Effect of aureomycin degradation products on resitant extracts. Isoaureomycin and aureone amide were previously shown to inhibit arylamine formation by sensitive cells and by cell-free extracts as strongly as aureomycin (Saz and Slie, 1954a (Saz, 1955) . It has as yet not been possible to demonstrate a cation requirement in the resistant extract.
DISCUSSION
The fact that an enzyme in a cell-free extract of aureomycin-resistant cells is also resistant to the inhibitory activity of aureomycin is of considerable theoretical interest. Various hypotheses have been considered in the past in attempts to understand the biochemical patterns which underlie resistance to antibiotics. First, there is always the possibility that resistant cells are less permeable to the antibiotic than sensitive cells. However, preliminary experiments with Cl36-aureomycin indicate that aureomycin uptake by both types of cells is of the same order of magnitude; and in addition, the fact that cell-free extracts are resistant would tend to eliminate this possibility. It is conceivable that resistant cells are able to inactivate the inhibitor by enzymatic modification of the molecule. There is no evidence for this phenomenon in the system being studied. The possibility consistent with the present data is the synthesis by the resistant cell of an altered enzyme which is refractory to the inhibitor. It should be mentioned that Sevag and Gots (1948) explained the induced resistance of pneumococcal cells and cell-free dehydrogenases to atabrin, propamidine and acriflavin on this basis.
The observation that the resistance increases with increasing concentration of resistant enzyme is perhaps significant in relation to the nature of the alteration in the resistant enzyme. It is possible that resistant enzyme in excess contributes an unknown compound which is able to reverse the activity of aureomycin. It is further possible that the enzyme of the resistant cell must combine with a larger amount of aureomycin before it is inhibited. The fact that partially purified -resistant enzyme contains firmly bound conjugated flavin (Saz, 1955; Saz, Martinez and Slie, in preparation) while the analogous sensitive enzyme contains only traces of the flavin is in accord with this thesis. An alternative hypothesis is based upon recent observations of Mahler and coworkers (1954) and Nason (1954a, 1954b) that various flavoproteins are indeed metalloflavoproteins. Since aureomycin is a potent chelating agent (Albert, 1953) and since there is a MnH requirement for sensitive nitro reductase (Saz and Slie, 1954b) , it is possible that aureomycin is active by virtue of its ability to compete for and bind metal components of the electron transport system. The resistant enzyme could be binding metal firmly enough to compete successfully with aureomycin.
The fact that certain antibiotically inactive degradation products of aureomycin are capable of inhibiting nitro reductase is disturbing if one wishes to use nitro reductase inhibition as a model in explaining the antibiotic activity of aureomycin. However, the observation that cross resistance to most of the degradation products of aureomycin does not develop when cells are made resistant to aureomycin is consistent with the idea that these products are inhibiting nitro reductase at a locus different from aureomycin. In addition, it has recently been observed that whereas aureomycin inhibition of nitro reductase is reversible by Mn++ (Saz and Slie, 1954b) , the inhibitory activity of isoaureomycin and aureone amide is not so reversed. This is further in accord with the thesis of different loci or mechanisms of inhibition by the breakdown products.
SUMMARY
A cell-free nitro reductase has been extracted from an aureomycin-resistant strain of Escherichia coli derived from an aureomycin-sensitive strain. This nitro reductase is resistant to the
